Vitamin D in renal transplantation - From biological mechanisms to clinical benefits

American Journal of Transplantation

Volumn 14, Issue 6, 2014, Pages 1259-1270

  McGregor, R ^a,b   Li, G ^a   Penny, H ^a   Lombardi, G ^a,b   Afzali, B ^a,b   Goldsmith, D J ^a,b  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b GUY'S AND ST THOMAS' NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

cancer; cardiovascular disease; immune system; renal transplantation; transplant rejection; vitamin D

Indexed keywords

CALCIUM; CD4 ANTIGEN; COLECALCIFEROL; CREATININE; FIBROBLAST GROWTH FACTOR 23; GAMMA INTERFERON; INTERLEUKIN 17; INTERLEUKIN 2; INTERLEUKIN 4; TRANSCRIPTION FACTOR FOXP3; VITAMIN D; VITAMIN RECEPTOR;

ADAPTIVE IMMUNITY; ANTIMICROBIAL ACTIVITY; APOPTOSIS; BIOLOGICAL FUNCTIONS; CALCIUM BLOOD LEVEL; CARDIOVASCULAR DISEASE; CELL ADHESION; CELL DIFFERENTIATION; CELL GROWTH; CELL POPULATION; CELL PROLIFERATION; CREATININE BLOOD LEVEL; CYTOKINE PRODUCTION; GRAFT RECIPIENT; HALF LIFE TIME; HUMAN; IMMUNE SYSTEM; INTERFERON PRODUCTION; KIDNEY TRANSPLANTATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REGULATORY T LYMPHOCYTE; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW; SYSTEMATIC REVIEW; UPREGULATION; VITAMIN D DEFICIENCY; VITAMIN SUPPLEMENTATION; GRAFT REJECTION; GRAFT SURVIVAL; PATHOPHYSIOLOGY; PHYSIOLOGY;

GRAFT REJECTION; GRAFT SURVIVAL; HUMANS; KIDNEY TRANSPLANTATION; VITAMIN D; VITAMIN D DEFICIENCY;

EID: 84901351694     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/ajt.12738     Document Type: Review

References (70)

1. Pludowski P, Holick MF, Pilz S, et al. 2013; Vitamin D effects on musculoskeletal health, immunity, autoimmunity, cardiovascular disease, cancer, fertility, pregnancy, dementia and mortality-a review of recent evidence. Autoimmun. Rev. 12: 976-989.
2. Pilz S, Iodice S, Zittermann A, Grant WB, Gandini S., 2011; Vitamin D status and mortality risk in CKD: a meta-analysis of prospective studies. Am. J. Kidney Dis. 58: 374-382.
3. Dm S, Cc M., 2007; Prevalence of 25 (OH) vitamin D (calcidiol) deficiency at time of renal transplantation: a prospective study. Clin. Transplant. 25: 683-688.
4. Baia LC, Humalda JK, Vervloet MG, Navis G, Bakker SJL, de Borst MH., 2013; Fibroblast growth factor 23 and cardiovascular mortality after kidney transplantation. Clin. J. Am. Soc. Nephrol. 8: 1968-1978.
5. Eyal O, Aharon M, Safadi R, Elhalel MD., 2013; Serum vitamin D levels in kidney transplant recipients: the importance of an immunosuppression regimen and sun exposure. Isr. Med. Assoc. J. 15: 628-633.
6. Shimada T, Hasegawa H, Yamazaki Y, et al. 2004; FGF-23 is a potent regulator of vitamin D metabolism and phosphate homeostasis. J. Bone Miner. Res. 19: 429-435. (Pubitemid 38787398)
7. Evenepoel P., 2013; Recovery versus persistence of disordered mineral metabolism in kidney transplant recipients. Semin. Nephrol. 33: 191-203.
8. Palmer SC, McGregor DO, Strippoli GF., 2007; Interventions for preventing bone disease in kidney transplant recipients. Cochrane database Syst. Rev. CD005015.
9. Bouillon R, Carmeliet G, Verlinden L, et al. 2008; Vitamin D and human health: lessons from vitamin D receptor null mice. Endocr. Rev. 29: 726-76.
10. Rigby WF, Stacy T, Fanger MW., 1984; Inhibition of T lymphocyte mitogenesis by 1,25-dihydroxyvitamin D3 (calcitriol). J. Clin. Invest. 74: 1451-1455. (Pubitemid 15200239)
11. Bhalla AK, Amento EP, Krane SM., 1986; Differential effects of 1,25-dihydroxyvitamin D3 on human lymphocytes and monocyte/macrophages: inhibition of interleukin-2 and augmentation of interleukin-1 production. Cell. Immunol. 98: 311-322. (Pubitemid 16112035)
12. Rigby WF, Yirinec B, Oldershaw RL, Fanger MW., 1987; Comparison of the effects of 1,25-dihydroxyvitamin D3 on T lymphocyte subpopulations. Eur. J. Immunol. 17: 563-566. (Pubitemid 17094157)
13. Meehan MA, Kerman RH, Lemire JM., 1992; 1,25-Dihydroxyvitamin D3 enhances the generation of nonspecific suppressor cells while inhibiting the induction of cytotoxic cells in a human MLR. Cell. Immunol. 140: 400-409.
14. Chambers ES, Hawrylowicz CM., 2011; The impact of vitamin D on regulatory T cells. Curr. Allergy Asthma Rep. 11: 29-36.
15. Povoleri GAM, Scottà C, Nova-Lamperti EA, John S, Lombardi G, Afzali B., 2013; Thymic versus induced regulatory T cells-who regulates the regulators ? Front. Immunol. 4: 169.
16. Heine G, Niesner U, Chang H-D, et al. 2008; 1,25-dihydroxyvitamin D(3) promotes IL-10 production in human B cells. Eur. J. Immunol. 38: 2210-228.
17. Zuber J, Grimbert P, Blancho G, et al. 2013; Prognostic significance of graft Foxp3 expression in renal transplant recipients: a critical review and attempt to reconcile discrepancies. Nephrol. Dial. Transplant 28: 1100-1111.
18. Mora JR, Iwata M, von Andrian UH., 2008; Vitamin effects on the immune system: vitamins A and D take centre stage. Nat. Rev. Immunol. 8: 685-698.
19. Afzali B, Lombardi G, Lechler RI., 2008; Pathways of major histocompatibility complex allorecognition. Curr. Opin. Organ Transplant. 13: 438-444.
20. Farias AS, Spagnol GS, Bordeaux-Rego P, et al. 2013; Vitamin D3 induces IDO(+) tolerogenic DCs and enhances Treg, reducing the severity of EAE. CNS Neurosci. Ther. 19: 269-277.
21. Nakayamada S, Takahashi H, Kanno Y, O'Shea JJ., 2012; Helper T cell diversity and plasticity. Curr. Opin. Immunol. 24: 297-302.
22. Segerer S, Cui Y, Eitner F, et al. 2001; Expression of chemokines and chemokine receptors during human renal transplant rejection. Am. J. Kidney Dis. 37: 518-531. (Pubitemid 32195291)
23. Romagnani P, Crescioli C., 2012; CXCL10: a candidate biomarker in transplantation. Clin. Chim. Acta. 413: 1364-1373.
24. Aksoy MO, Yang Y, Ji R, et al. 2006; CXCR3 surface expression in human airway epithelial cells: cell cycle dependence and effect on cell proliferation. Am. J. Physiol. Lung Cell. Mol. Physiol. 290: L909-18. (Pubitemid 43725053)
25. Cockwell P., 2002; Chemoattraction of T cells expressing CCR5, CXCR3 and CX3CR1 by proximal tubular epithelial cell chemokines. Nephrol. Dial. Transplant. 17: 734-744. (Pubitemid 34521121)
26. Fabri M, Stenger S, Shin D-M, et al. 2011; Vitamin D is required for IFN-gamma-mediated antimicrobial activity of human macrophages. Sci. Transl. Med. 3: 104ra102.
27. Wang T-T, Nestel FP, Bourdeau V, et al. 2004; Cutting edge: 1,25-dihydroxyvitamin D3 is a direct inducer of antimicrobial peptide gene expression. J. Immunol. 173: 2909-212.
28. Adorini L, Amuchastegui S, Daniel KC., 2005; Prevention of chronic allograft rejection by Vitamin D receptor agonists. Immunol. Lett. 100: 34-41. (Pubitemid 41262032)
29. Young M, Day T., 2013; Immune Regulatory Activity of Vitamin D3 in Head and Neck Cancer. Cancers (Basel). 5: 1072-1085.
30. Brown AJ, Slatopolsky E., 2008; Vitamin D analogs: therapeutic applications and mechanisms for selectivity. Mol. Aspects Med. 29: 433-452.
31. Cantorna MT, Hullett DA, Redaelli C, et al. 1998; 1,25-Dihydroxyvitamin D3 prolongs graft survival without compromising host resistance to infection or bone mineral density. Transplantation 66: 828-831. (Pubitemid 28487453)
32. Ardalan MR, Maljaei H, Shoja MM, et al. 2007; Calcitriol started in the donor, expands the population of CD4+ CD25+ T cells in renal transplant recipients. Transplant. Proc. 39: 951-953. (Pubitemid 46764934)
33. Van Etten E, Mathieu C., 2005; Immunoregulation by 1, 25-dihydroxyvitamin D3: basic concepts. J. Steroid Biochem. Mol. Biol. 97: 93-101.
34. Cunningham J, Locatelli F, Rodriguez M., 2011; Secondary hyperparathyroidism: pathogenesis, disease progression, and therapeutic options. Clin. J. Am. Soc. Nephrol. 6: 913-921.
35. Kalantar-Zadeh K, Molnar MZ, Kovesdy CP, Mucsi I, Bunnapradist S., 2012; Management of mineral and bone disorder after kidney transplantation. Curr. Opin. Nephrol. Hypertens. 21: 389-403.
36. Palmer SC, McGregor DO, Craig JC, Elder G, Macaskill P, S G., 2009; Vitamin D compounds for people with chronic kidney disease not requiring dialysis (Review). Cochrane Database Syst. Rev.
37. Sadlier DM, Magee CC., 2007; Prevalence of 25(OH) vitamin D (calcidiol) deficiency at time of renal transplantation: a prospective study. Clin. Transplant. 21: 683-688. (Pubitemid 350056133)
38. Falkiewicz K, Boratynska M, Speichert-Bidzińska B, et al. 2009; 1,25-dihydroxyvitamin D deficiency predicts poorer outcome after renal transplantation. Transplant. Proc. 41: 3002-3005.
39. Kim H, Kang S-W, Yoo T-H, et al. 2012; The impact of pretransplant 25-hydroxy vitamin D deficiency on subsequent graft function: an observational study. BMC Nephrol. 13: 22.
40. Bienaimé F, Girard D, Anglicheau D, et al. 2013; Vitamin d status and outcomes after renal transplantation. J. Am. Soc. Nephrol. 24: 831-41.
41. Wesseling-Perry K, Tsai EW, Ettenger RB, Jüppner H, Salusky IB., 2011; Mineral abnormalities and long-term graft function in pediatric renal transplant recipients: a role for FGF-23 ? Nephrol. Dial. Transplant 26: 3779-3784.
42. Tanaci N, Karakose H, Guvener N, Tutuncu N, Colak T, Haberal M., 2003; Influence of 1,25-dihydroxyvitamin D3 as an immunomodulator in renal transplant recipients: a retrospective cohort study. Transplant. Proc. 35: 2885-2887. (Pubitemid 38102080)
43. Özdemir BH, Özdemir aa, Sezer S, Çolak T, Haberal M., 2011; Influence of 1,25-dihydroxyvitamin D3 on human leukocyte antigen-DR expression, macrophage infiltration, and graft survival in renal allografts. Transplant. Proc. 43: 500-503.
44. Uyar M, Sezer S, Arat Z, Elsurer R, Ozdemir FN, Haberal M., 2006; 1,25-dihydroxyvitamin D(3) therapy is protective for renal function and prevents hyperparathyroidism in renal allograft recipients. Transplant. Proc. 38: 2069-2073. (Pubitemid 46068497)
45. Courbebaisse M, Xu-Dubois Y-C, Thervet E, et al. 2011; Cholecalciferol supplementation does not protect against renal allograft structural and functional deterioration: a retrospective study. Transplantation 91: 207-212.
46. Van der Rhee H, Coebergh JW, de Vries E., 2013; Is prevention of cancer by sun exposure more than just the effect of vitamin D? A systematic review of epidemiological studies. Eur. J. Cancer 49: 1422-1436.
47. Ducloux D, Courivaud C, Bamoulid J, Kazory A, Dumoulin G, Chalopin J-M., 2008; Pretransplant serum vitamin D levels and risk of cancer after renal transplantation. Transplantation 85: 1755-1759.
48. Marcén R, Jimenez S, Fernández-Rodriguez A, et al. 2012; Are low levels of 25-hydroxyvitamin D a risk factor for cardiovascular diseases or malignancies in renal transplantation ? Nephrol. Dial. Transplant 27 (Suppl 4) iv47-52.
49. Obi Y, Ichimaru N, Hamano T, et al. 2012; Orally active vitamin d for potential chemoprevention of posttransplant malignancy. Cancer Prev. Res. 5: 1229-1235.
50. Ulrich C, Jürgensen JS, Degen A, et al. 2009; Prevention of non-melanoma skin cancer in organ transplant patients by regular use of a sunscreen: a 24 months, prospective, case-control study. Br. J. Dermatol. 161: 78-84.
51. Penny H, Frame S, Dickinson F, et al. 2012; Determinants of vitamin D status in long-term renal transplant patients. Clin. Transplant. 26: E617-23.
52. Autier P, Gandini S., 2007; Vitamin D supplementation and total mortality: a meta-analysis of randomized controlled trials. Arch. Intern. Med. 167: 1730-1737. (Pubitemid 47403059)
53. Elamin MB, Abu Elnour NO, Elamin KB, et al. 2011; Vitamin D and cardiovascular outcomes: a systematic review and meta-analysis. J. Clin. Endocrinol. Metab. 96: 1931-1942.
54. Gunta SS, Thadhani RI, Mak RH., 2013; The effect of vitamin D status on risk factors for cardiovascular disease. Nat. Rev. Nephrol., 1-11.
55. Janssen MJW, Wielders JPM, Bekker CC, et al. 2012; Multicenter comparison study of current methods to measure 25-hydroxyvitamin D in serum. Steroids 77: 1366-1372.
56. Nanzer AM, Chambers ES, Ryanna K, et al. 2013; Enhanced production of IL-17A in patients with severe asthma is inhibited by 1α,25- dihydroxyvitamin D3 in a glucocorticoid-independent fashion. J. Allergy Clin. Immunol. 132: 297-304.e3.
57. Fraser WD, Milan AM., 2013; Vitamin D assays: past and present debates, difficulties, and developments. Calcif. Tissue Int. 92: 118-127.
58. Elder GJ., 2007; Vitamin D levels, bone turnover and bone mineral density show seasonal variation in patients with chronic kidney disease stage 5. Nephrology (Carlton). 12: 90-94.
59. Kalantar-Zadeh K, Kovesdy CP., 2009; Clinical outcomes with active versus nutritional vitamin D compounds in chronic kidney disease. Clin. J. Am. Soc. Nephrol. 4: 1529-1539.
60. Agarwal R, Hynson JE, Hecht TJW, Light RP, Sinha AD., 2011; Short-term vitamin D receptor activation increases serum creatinine due to increased production with no effect on the glomerular filtration rate. Kidney Int. 80: 1073-1079.
61. Leckstroem DC, Salzer J, Goldsmith DJA., 2014; The trials and tribulations of vitamin D-Time for the "sunshine" vitamin to come in out of the cold-or just more broken promises?-In press. Expert Rev. Endocrinol. Metab.
62. Wissing KM, Broeders N, Moreno-Reyes R, Gervy C, Stallenberg B, Abramowicz D., 2005; A controlled study of vitamin D3 to prevent bone loss in renal-transplant patients receiving low doses of steroids. Transplantation 79: 108-115. (Pubitemid 40140008)
63. Courbebaisse M, Thervet E, Souberbielle JC, et al. 2009; Effects of vitamin D supplementation on the calcium-phosphate balance in renal transplant patients. Kidney Int. 75: 646-651.
64. Boudville NC, Hodsman AB., 2006; Renal function and 25-hydroxyvitamin D concentrations predict parathyroid hormone levels in renal transplant patients. Nephrol. Dial. Transplant 21: 2621-2624. (Pubitemid 44644541)
65. Thiem U, Heinze G, Segel R, et al. 2009; VITA-D: cholecalciferol substitution in vitamin D deficient kidney transplant recipients: a randomized, placebo-controlled study to evaluate the post-transplant outcome. Trials 10: 36.
66. Thervet E., 2013; VITamine D Supplementation in RenAL Transplant Recipients-VITALE. Clinicaltrials.gov.
67. Tsubakihara Y., 2013; Correcting Anemia and Native Vitamin D Supplementation in Kidney Transplant Recipients (CANDLE-KIT). Cinicaltrials.gov.
68. Kasiske BL, Zeier MG, Chapman JR, et al. 2010; KDIGO clinical practice guideline for the care of kidney transplant recipients: a summary. Kidney Int. 77: 299-311.
69. Holick MF., 2007; Vitamin D deficiency. N. Engl. J. Med. 357: 266-281.
70. Saintonge S, Bang H, Gerber LM., 2009; Implications of a new definition of vitamin D deficiency in a multiracial us adolescent population: the National Health and Nutrition Examination Survey III. Pediatrics 123: 797-803.